| Nine Months Results of Dr Reddys Laboratories (in Rs. Cr.) |
Dec '21 |
Dec '20 |
Dec '19 |
Dec '18 |
Dec '17 |
|
| Net Sales/Income from operations |
10,736.50 |
9,998.40 |
8,972.70 |
7,858.30 |
6,826.00 |
|
| Other Operating Income |
-- |
-- |
26.00 |
122.00 |
41.00 |
|
| Total Income From Operations |
10,736.50 |
9,998.40 |
8,998.70 |
7,980.30 |
6,867.00 |
|
| EXPENDITURE |
|
|
|
|
|
|
| Consumption of Raw Materials |
2,051.70 |
2,450.00 |
1,902.20 |
1,579.90 |
1,437.00 |
|
| Purchase of Traded Goods |
2,033.50 |
925.70 |
891.10 |
632.10 |
457.00 |
|
| Increase/Decrease in Stocks |
-333.90 |
-416.40 |
-167.10 |
-40.30 |
-12.70 |
|
| Power & Fuel |
-- |
-- |
-- |
-- |
-- |
|
| Employees Cost |
1,825.70 |
1,724.50 |
1,513.60 |
1,441.90 |
1,379.70 |
|
| Depreciation |
609.10 |
624.30 |
596.90 |
576.40 |
584.10 |
|
| Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
| Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
800.70 |
|
| R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
| Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
| Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
| Other Expenses |
3,235.30 |
2,780.70 |
2,510.10 |
2,503.60 |
1,801.80 |
|
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
1,315.10 |
1,909.60 |
1,751.90 |
1,286.70 |
419.40 |
|
| Other Income |
367.30 |
719.50 |
615.80 |
165.70 |
130.90 |
|
| P/L Before Int., Excpt. Items & Tax |
1,682.40 |
2,629.10 |
2,367.70 |
1,452.40 |
550.30 |
|
| Interest |
25.30 |
29.80 |
36.00 |
48.10 |
48.70 |
|
| P/L Before Exceptional Items & Tax |
1,657.10 |
2,599.30 |
2,331.70 |
1,404.30 |
501.60 |
|
| Exceptional Items |
-- |
-- |
-- |
-- |
-- |
|
| P/L Before Tax |
1,657.10 |
2,599.30 |
2,331.70 |
1,404.30 |
501.60 |
|
| Tax |
453.60 |
724.40 |
-103.20 |
329.80 |
111.30 |
|
| P/L After Tax from Ordinary Activities |
1,203.50 |
1,874.90 |
2,434.90 |
1,074.50 |
390.30 |
|
| Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
| Extra Ordinary Items |
-- |
-- |
-- |
-- |
-- |
|
| Net Profit/(Loss) For the Period |
1,203.50 |
1,874.90 |
2,434.90 |
1,074.50 |
390.30 |
|
| Equity Share Capital |
83.20 |
83.10 |
83.10 |
83.00 |
82.90 |
|
| Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
-- |
-- |
|
| Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
| EPS Before Extra Ordinary |
|
|
|
|
|
|
| Basic EPS |
72.56 |
113.05 |
146.89 |
64.75 |
23.54 |
|
| Diluted EPS |
72.38 |
112.73 |
146.62 |
64.67 |
23.49 |
|
| EPS After Extra Ordinary |
|
|
|
|
|
|
| Basic EPS. |
72.56 |
113.05 |
146.89 |
64.75 |
23.54 |
|
| Diluted EPS. |
72.38 |
112.73 |
146.62 |
64.67 |
23.49 |
|
| Public Share Holding |
|
|
|
|
|
|
| No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
| Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
| a) Pledged/Encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
| b) Non-encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
